Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Dr. Nicolas Girard, MD, PhD, explores new treatments for advanced HER2-positive non-small cell lung cancer (NSCLC). Highlighting the challenges faced by this orphan patient group, he discusses the…
Yogitha Namasani, MD discusses two recent leukemia cases. The first involved a patient with acute leukemia diagnosed through peripheral smear, flow cytometry, and bone marrow studies, which confirmed…
Confused about the differences between osteoarthritis and rheumatoid arthritis? Learn how osteoarthritis results from mechanical wear and tear on weight-bearing joints, causing degeneration and inflammation. Contrast this with…
Allison Betof Warner, MD from Stanford Healthcare discusses recent advancements in treating advanced melanoma with a newly FDA-approved cell-based therapy. This innovative treatment is designed for patients who…
Delve into the importance of understanding IgA nephropathy, a condition that can lead to permanent kidney failure, requiring dialysis or transplantation. Patients with excessive protein loss in the…
Josh Galdi, PharmD, BCPS and Hannah N. Lambert, PharmD discuss the current understanding of IgA nephropathy with Anor Shaw, MD. They explore the nature of this common glomerular…
This video discusses the management of IgA nephropathy, a common and incurable kidney disease. Treatment aims to control the disease and delay kidney damage progression. Lifestyle changes, such…
Professor Jonathan Barratt, head of the Renal Research Group within the College of Life Sciences at the University of Leicester, discusses the latest advancements in the treatment of…
Rafael Fonseca, MD, discusses the evolving landscape of multiple myeloma treatment. While traditionally deemed incurable, Dr. Fonseca highlights a growing fraction of patients achieving sustained, durable, and potentially…
In this webinar, we delve into the advancements in Pompe disease treatment, particularly focusing on the progression from mouse models to clinical trials. Key developments include the testing…
